EUS-guided cyanoacrylate injection into the perforating vein versus direct endoscopic injection in the treatment of gastric varices
Endoscopy International Open · 01.02.2023 · 11 (02) · E202-E210
DOI: 10.1055/a-1984-7070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.02.2023. Verfasst von Fady Sabry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mansoura University Faculty of Medicine, Department of Gastroenterology and Hepatology, Mansoura, Egypt. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and study aims Endoscopic injection of gastric varices (GVs) using cyanoacrylate (CYA) is associated with significant adverse events (AEs). We aimed to compare the efficacy and safety of endoscopic ultrasound (EUS)-guided CYA injection into the perforating vein versus direct endoscopic injection (DEI) of CYA in treatment of high-risk GVs. Patients and methods This was a randomized controlled trial that included 52 patients with high-risk GVs. Group A underwent EUS-guided injection into the perforator vein and Group B underwent DEI of 1 mL CYA. Endoscopic examination and Doppler EUS were repeated after 3 months to confirm eradication. Obliteration by Doppler EUS was considered by absence of Doppler flow within the varix. Repeated injection was performed in the absence of obliteration. Doppler EUS examination was repeated at 3 and 6 months after each injection.
Results
Forty-three patients including 27 males and 16 females with mean age 57 years completed the study. Variceal obliteration was achieved during the index session after 3 months in eight of 21 (38.1 %) in group B compared to 17 of 22 (77.2 %) in group A (P = 0.014). There was a significant difference in the amount of CYA needed to achieve obliteration in group B compared to group A (2 vs.1 mL, P = 0.027). There was no statistically significant difference in the overall AE rate between group A and group B (4.5 % vs. 14.3 %, P = 0.345).
Conclusions
EUS-guided CYA injection into the perforating veins achieved less amount of CYA, fewer number of sessions to obliteration, and similar overall AE rates in the treatment of high-risk GVs compared to DEI.
Autor:innen und Institutionen
- Mansoura University Faculty of Medicine, Department of Gastroenterology and Hepatology, Mansoura, Egypt.
Zitieren
APA
Sabry, F., Seif, S., Eldesoky, A., Hakim, H., & Altonbary, A. Y. (2023). EUS-guided cyanoacrylate injection into the perforating vein versus direct endoscopic injection in the treatment of gastric varices. Endoscopy International Open, 11(02), E202-E210. https://doi.org/10.1055/a-1984-7070
Vancouver
Sabry F, Seif S, Eldesoky A, Hakim H, Altonbary AY. EUS-guided cyanoacrylate injection into the perforating vein versus direct endoscopic injection in the treatment of gastric varices. Endoscopy International Open. 2023;11(02):E202-E210. doi:10.1055/a-1984-7070
BibTeX
@article{Sabry2023,
author = {Sabry, Fady and Seif, Seham and Eldesoky, Ayman and Hakim, Hazem and Altonbary, Ahmed Youssef},
title = {EUS-guided cyanoacrylate injection into the perforating vein versus direct endoscopic injection in the treatment of gastric varices},
journal = {Endoscopy International Open},
year = {2023},
volume = {11},
number = {02},
pages = {E202--E210},
doi = {10.1055/a-1984-7070}
}
EUVIMED